StockData
Rigel Pharmaceuticals Inc logo

Rigel Pharmaceuticals Inc (RIGL) stock

RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$42.92−0.81 (-1.85%)

Close on Nov 17, 2026Market cap $801.74MP/E 2.7Yield –

Rigel Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Rigel Pharmaceuticals's price to book ratio was 2.1× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 1.3× to 124.2×, with a median of 6.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.1×−4.6
2025Dec 31, 20256.7×−22.4
2022Jul 29, 202229.1×+20.0
2021Dec 31, 20219.2×−2.4
2020Dec 31, 202011.6×+6.4
2019Dec 31, 20195.2×+2.4
2018Dec 31, 20182.8×−3.7
2017Dec 29, 20176.5×+3.3
2016Dec 30, 20163.2×+0.4
2015Dec 31, 20152.8×+1.4
2014Dec 31, 20141.3×+0.4
2013Dec 31, 20131.0×−1.7
2012Dec 31, 20122.7×+0.5
2011Dec 30, 20112.2×−0.6
2010Dec 31, 20102.8×–

More Rigel Pharmaceuticals figures

See a number that looks wrong?